MedRx : Prospect of NDA Re-Submission for MRX-5LBT -October 10, 2023 at 02:04 am EDT
News Release Dated October 10, 2023 MEDRx Co., Ltd. Yonehiro Matsumura, CEO Stock code: 4586, TSE Growth ...
United States Yonehiro Matsumura Drug Administration D Western Therapeutics Institute Inc Management Department Medrx Co Ltd
Source: marketscreener.com